The United States has officially lost its measles elimination status after 26 years, a shift shown by a new, urgent report detailing the severe risks the virus poses to expectant mothers.
While national health agencies have tracked broader infection rates, a specific analysis published in NEJM Evidence reveals that 112 pregnant women were diagnosed with measles between January 2025 and late September 2026.
This data, which provides the first national picture of maternal measles complications, highlights a reality that many clinicians are now racing to address: measles during pregnancy is not just a standard respiratory illness, but a condition that can trigger pneumonia, premature births, and dangerous infections in newborns.
The report, which arrived via an independent medical journal rather than a direct Centers for Disease Control and Prevention alert, clarifies that 13 babies in the study met the clinical definition of congenital measles. Of the 19 infants delivered within two weeks of their mother developing a rash, eight were born prematurely and eight required admission to a neonatal intensive care unit.
The findings suggest that the true scope of the crisis may be even wider than initial figures indicate, as CIDRAP News reports that state health departments have documented at least 167 measles infections in pregnant people across the country during this period.

For those on the front lines of maternal-fetal medicine, the lack of a centralized, urgent warning from federal health authorities has been a source of frustration. Dr. Eric Rubin, editor of NEJM and a physician at Mass General Brigham, noted in an interview with WGBH that while he is heartened the data is now public, there have been lingering concerns regarding the flow of critical safety information.
“There have been concerns about important safety data not being coming from the CDC,” Rubin said.
“It’s important to remember that the men and women who work at the CDC are a very dedicated group who are continuing to produce a lot of information that’s really important to the public’s health. I’m not sure we’re seeing all of it, but in this case, we are seeing it.”
The medical stakes are high because the standard measles, mumps, and rubella (MMR) vaccine cannot be administered during pregnancy. This leaves unvaccinated individuals in a vulnerable position if exposed. Current medical guidance emphasizes that susceptible pregnant women who are exposed to the virus should receive immune globulin within six days to provide passive immunity.
As Kevin Ault, an obstetrician-gynecologist at Penn State Health, told the Genetic Literacy Project, a timely national alert could have ensured that emergency rooms and hospitals were fully aware of this treatment option for patients arriving with potential symptoms.
The geographic distribution of these cases remains uneven, with Pennsylvania reporting a disproportionately high number of infections among pregnant women, according to reporting by Iheart. While the U.S. has logged more than 5,400 total measles cases and at least 10 deaths in 2026, the specific vulnerability of the “mother-fetus dyad” has led doctors to urge increased preconception counseling.
As Dr. Sharee Livingston, an OBGYN in Central Pennsylvania, explained to Iheart, the clinical management of these cases is exceptionally difficult: “You have to watch the mother fetus dyad so closely because of the risk of fetal death.”
The challenge for public health officials is now twofold: managing an active resurgence and rebuilding the community trust necessary to raise vaccination rates, which have dipped below the 95% threshold required for herd immunity in many areas.
“We know how to control measles,” Rubin told WGBH. “It’s very simple. We have got a vaccine that is safe and effective. That’s been used for years and we’re simply not using it.”
